FEED Overview

ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.

Wall Street analysts forecast FEED stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FEED is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

ENvue Medical Inc revenue for the last quarter amounts to 722.00K USD, increased 92.02

ENvue Medical Inc. EPS for the last quarter amounts to -0.91 USD, decreased -97.68

ENvue Medical Inc (FEED) has 15 emplpoyees as of March 02 2026.

Today FEED has the market capitalization of 2.26M USD.